Federal Register #2026-15833

CMS Finalizes FY 2027 Medicare Payment Updates for Hospital Technologies and Therapies

This update from the Centers for Medicare & Medicaid Services (CMS) outlines finalized changes to Medicare payment systems and policies for acute care and long-term care hospitals for FY 2027. - Government Buyer: - Department of Health and Human Services (HHS) - Centers for Medicare & Medicaid Services (CMS) - Office of the Secretary - Key OEMs and Products: - Medtronic: AGENT Paclitaxel-Coated Balloon Catheter - Stryker: iFuse Bedrock Granite Implant System - Carlsmed: Aprevo Intervertebral Body Fusion Device - BONESUPPORT AB: CERAMENT G and CERAMENT V - AeroPace: AeroPace System - Glytec: Command Center Electronic Glycemic Management System - Sumitomo Pharma: COBENFYTM (Xanomeline and Trospium Chloride) - Nabriva Therapeutics: CONTEPOTM (Fosfomycin) - CellTrans: Donislecel-jujn (Pancreatic Islet Cell Transplantation) - On Target Laboratories: CYTALUX (Pafolacianine) - Products/Services Requested: - New and updated medical devices, drugs, and software systems for hospital use - Notable items include spinal fusion implants, antimicrobial bone fillers, novel schizophrenia therapies, vascular intervention devices, and advanced glycemic management software - Specific part numbers are not provided; products are referenced by trade names - Unique/Notable Requirements: - New technology add-on payments for select products, with eligibility based on FDA approval dates and clinical improvement evidence - ICD-10 coding changes affecting reimbursement and severity group assignments - Emphasis on clinical coherence in procedure coding and payment groupings - No direct procurement of goods or services; changes affect hospital reimbursement and technology adoption incentives

Description

This final rule published by the Centers for Medicare & Medicaid Services details updates to the Medicare hospital inpatient prospective payment systems (IPPS) for acute care hospitals and the long-term care hospital prospective payment system for fiscal year 2027. It includes revisions to payment policies, annual payment rates, and changes relating to Medicare graduate medical education and nursing and allied health education payments. The rule also finalizes requirements for quality programs, adopts new quality measures, modifies data reporting requirements, and adopts updated versions of certain health information technology standards. The rule is effective October 1, 2026, and includes policy changes affecting various hospital programs and payment models.

View original listing